DGAP-News: Exiqon launches new products for the research and development of LNA(tm) based drugs
Exiqon A/S
10.10.2011 08:45
—————————————————————————
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value products for
gene expression analysis, today announced the expansion of its product offering
to include LNA(tm) products for the research and development of RNA targeted
medicine including LNA(tm) as the active pharmaceutical ingredient.
The first new products being offered include the following:
— oxy-LNA(tm) amidites in
